Yes, they received grants. Yes also that they developed the finished products which were then purchased at a discounted rate and they received Emergency Use Audits and accelerated review processes to put them out there. Pretty much anyone that’s wanted to get their COVID vaccines and boosters has gotten them and they didn’t have to pay out of pocket at the time of injection. J&J, Moderna, Sanofi and AstraZeneca are now free to pursue other opportunities. Why shouldn’t they make a profit?
If there is a credible risk of vaccines not being developed, as you say, perhaps it's time to think about either: a) nationalizing the key players in pharmaceutical industry, or b) introducing laws (if none already exist) that allow governments to compel these companies to allocate resources to work on specific projects.
Vaccines are not a luxury item sold on a free market and we shouldn't have to rely on profit-seeking companies to develop and appropriately distribute them in the most beneficial way, it's simply incompatible with what's best for humanity during a pandemic. We've seen this play out, US & EU countries created massive stockpiles of vaccines because they had dozens of billions of taxpayer money to pay for extortionate prices while poorer countries still had 1% vaccination rates.
This has lead to hundreds of millions (!) of doses of Covid vaccines expiring and being wasted. The side effect of this is increased likelihood of mutations that has the potential to harm everyone.
Endemic. Pandemic implies an end. They also make money off flu vaccines and measles vaccines. What’s the difference? That they can make money at all doing it is why they continue to do so and why governments don’t have to try and figure out supply and demand themselves.
> If there is a credible risk of vaccines not being developed, as you say, perhaps it's time to think about either: a) nationalizing the key players in pharmaceutical industry, or b) introducing laws (if none already exist) that allow governments to compel these companies to allocate resources to work on specific projects.
It’s not just about developing vaccines in the middle of pandemics; it’s about having an incentive to develop every type of vaccine we could possibly need, eventually, finding new applications for vaccine technology and improving the development and manufacturing processes. You need smart people, smart people want money and not just the thanks of their neighbors, ergo profits. Sure the government is a cushy job, but private sector pays more and as long as there’s profits, the “key players” as you call them aren’t limited to the ones that exist today.
> Vaccines are not a luxury item sold on a free market
I don’t know about “luxury” but they are sold on a free market.
> and we shouldn't have to rely on profit-seeking companies to develop and appropriately distribute them in the most beneficial way, it's simply incompatible with what's best for humanity during a pandemic.
The COVID vaccines set a record for research, development and dispersal and those profit seeking corporations pulled that off both because they could and they had an incentive to.
> We've seen this play out, US & EU countries created massive stockpiles of vaccines because they had dozens of billions of taxpayer money to pay for extortionate prices while poorer countries still had 1% vaccination rates.
Would you feel better about the US, UK, EU, and Israel putting themselves at the front of the line as long as they had nationalized their pharmaceuticals companies first?
> Since 2006, Congress has appropriated hundreds of millions of dollars that BARDA used to develop the scientific infrastructure to produce vaccines in response to the threat of pandemic flu. Thus, the basic research undergirding the COVID-19 vaccines was largely publicly supported.
> Recent estimates indicate that the government spent more than $900 million dollars supporting non-clinical studies and research to accelerate movement of candidate vaccines into clinical trials at companies such as Johnson and Johnson, Sanofi, Merck, and Moderna.
> Johnson and Johnson, Moderna, Sanofi, and AstraZeneca together are estimated to have received more than $2.7 billion from the federal government to cover expenses related to human trials. The bulk of money was directed at Phase III trials, which compare new treatments against standard care and where most human test costs are incurred.
https://www.healthaffairs.org/do/10.1377/forefront.20210512....
https://www.fiercepharma.com/pharma/after-nearly-1b-research...